GlassScriptPhysician profile
Manoj Thangam
NPI 1205270204
$76,051.25
in general payments reported to CMS, 2019-2025
23 companies · $1,640 in 2025
The $1,640 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $15K · 2021: $52K · 2022: $3,518 · 2023: $1,669 · 2024: $1,562 · 2025: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,728 · Travel and Lodging: $1,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,727.51 |
| Travel and Lodging | $1,142.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $68,181.90 | 2020-2025 | Ekosonic, Watchman Flx |
| Penumbra, INC. | $1,535.52 | 2022-2025 | Indigo System |
| Abiomed | $1,220.40 | 2019-2025 | Impella |
| Cardiovascular Systems INC. | $880.01 | 2020-2022 | |
| Abbott Laboratories | $809.94 | 2019-2023 | Diamondback Coronary |
| Inari Medical, INC. | $606.51 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $522.91 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $334.44 | 2021-2025 | Coronary Other |
| Medtronic, INC. | $324.84 | 2022-2024 | Hawkone |
| Agepha Pharma Fz LLC | $310.86 | 2025 | Lodoco |
| Surmodics, INC. | $191.37 | 2023 | Pounce Thrombectomy |
| Astrazeneca Pharmaceuticals LP | $191.34 | 2020-2021 | |
| Stryker Corporation | $175.05 | 2025 | Revcore Thrombectomy Catheter, Artix Mt, Flowtriever |
| Biotronik INC. | $164.98 | 2022 | |
| Arrow International, INC. | $145.12 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $119.19 | 2022 | |
| Chiesi USA, INC. | $108.17 | 2019-2021 | |
| Inquis Medical, INC. | $76.60 | 2024-2025 | Aventus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.22 | 2019-2021 | |
| Medtronic Vascular, INC. | $37.17 | 2020 | |
| Cardinal Health 200 LLC | $23.25 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.75 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $14.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manoj Thangam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.